A Critical Role for IL-21 Receptor Signaling in the Coxsackievirus B3-Induced Myocarditis.

about

A Critical Role for IL-21 Receptor Signaling in the Coxsackievirus B3-Induced Myocarditis.

Item

http://www.wikidata.org/entity/Q38760593

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A Critical Role for IL-21 Rece ...... evirus B3-Induced Myocarditis.

@en

type

Item

label

A Critical Role for IL-21 Rece ...... evirus B3-Induced Myocarditis.

@en

prefLabel

A Critical Role for IL-21 Rece ...... evirus B3-Induced Myocarditis.

@en

P1476

A Critical Role for IL-21 Rece ...... evirus B3-Induced Myocarditis.

@en

P2093

Bao-Ping Tan

http://www.w3.org/2001/XMLSchema#string

Fan Yang

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Wen-Hong Mo

http://www.w3.org/2001/XMLSchema#string

Wen-Wu Liang

http://www.w3.org/2001/XMLSchema#string

Xiao-Mou Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

Interleukin-21: Basic Biology and Implications for Cancer and Autoimmunity

IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells

Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of coxsackievirus b3-induced viral myocarditis reduces myocardium inflammation.

Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.

A fundamental role for interleukin-21 in the generation of T follicular helper cells.

Expression of IL-23/Th17 pathway in a murine model of Coxsackie virus B3-induced viral myocarditis.

Increased frequency of follicular helper T cells in mice viral myocarditis is relevant with anti-ANT antoantibody.

Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity

A phase 1 trial of recombinant human IL-21 in combination with cetuximab in patients with metastatic colorectal cancer.

P2888

s10753-017-0586-5

P304

1428-1435

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10753-017-0586-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085609668

http://www.w3.org/2001/XMLSchema#string

P698

28550395

http://www.w3.org/2001/XMLSchema#string

P921

Coxsackievirus